Literature DB >> 12020124

Dantrolene downregulates the gene expression and activity of the ubiquitin-proteasome proteolytic pathway in septic skeletal muscle.

Curtis J Wray1, Xiaoyan Sun, Gyu I Gang, Per-Olof Hasselgren.   

Abstract

BACKGROUND: In previous studies, dantrolene prevented sepsis-induced muscle proteolysis, but the influence of dantrolene on the expression and activity of the ubiquitin-proteasome proteolytic pathway is not known. In addition, the role of glucocorticoids in the anabolic effect of dantrolene is not well understood.
METHODS: Sepsis was induced in rats by cecal ligation and puncture (CLP). Other rats underwent sham-operation. Groups of rats were treated with dantrolene (10 mg/kg) administered 2 h before and 8 h after sham-operation or CLP. Sixteen hours after sham-operation or CLP, mRNA levels for ubiquitin, the ubiquitin ligase E3alpha, and the 20S proteasome subunit C3 were determined by dot-blot analysis. In additional experiments, the effect of dantrolene on protein degradation was tested in L6 myotubes cultured in the absence or presence of dexamethasone.
RESULTS: Treatment of rats with dantrolene prevented the sepsis-induced increase in mRNA levels for ubiquitin, the ubiquitin ligase E3alpha, and the 20S proteasome subunit C3. In additional experiments, treatment of cultured myotubes with dantrolene reduced protein degradation in both the absence and the presence of dexamethasone.
CONCLUSIONS: The results suggest that dantrolene can prevent sepsis-induced activation of the ubiquitin-proteasome proteolytic pathway in skeletal muscle and that dantrolene reduces muscle protein degradation independent of glucocorticoids. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020124     DOI: 10.1006/jsre.2002.6416

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  9 in total

Review 1.  Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation.

Authors:  Per-Olof Hasselgren; Nima Alamdari; Zaira Aversa; Patricia Gonnella; Ira J Smith; Steven Tizio
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

Review 2.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 3.  The "parallel pathway": a novel nutritional and metabolic approach to cancer patients.

Authors:  Maurizio Muscaritoli; Alessio Molfino; Gianfranco Gioia; Alessandro Laviano; Filippo Rossi Fanelli
Journal:  Intern Emerg Med       Date:  2010-07-02       Impact factor: 3.397

4.  Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy.

Authors:  Susan D Kraner; Qingbo Wang; Kevin R Novak; Dongmei Cheng; David R Cool; Junmin Peng; Mark M Rich
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

5.  Mechanism of attenuation by beta-hydroxy-beta-methylbutyrate of muscle protein degradation induced by lipopolysaccharide.

Authors:  Steven T Russell; Michael J Tisdale
Journal:  Mol Cell Biochem       Date:  2009-04-30       Impact factor: 3.396

6.  Apocynin attenuates diaphragm oxidative stress and protease activation during prolonged mechanical ventilation.

Authors:  Joseph M McClung; Darin Van Gammeren; Melissa A Whidden; Darin J Falk; Andreas N Kavazis; Matt B Hudson; Ghislaine Gayan-Ramirez; Marc Decramer; Keith C DeRuisseau; Scott K Powers
Journal:  Crit Care Med       Date:  2009-04       Impact factor: 7.598

7.  Dexamethasone stimulates store-operated calcium entry and protein degradation in cultured L6 myotubes through a phospholipase A(2)-dependent mechanism.

Authors:  Kiyoshi Itagaki; Michael Menconi; Bozena Antoniu; Qin Zhang; Patricia Gonnella; David Soybel; Carl Hauser; Per-Olof Hasselgren
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-27       Impact factor: 4.249

Review 8.  The cytoprotective effects of dantrolene: a ryanodine receptor antagonist.

Authors:  Saadet Inan; Huafeng Wei
Journal:  Anesth Analg       Date:  2010-09-22       Impact factor: 6.627

9.  UBE2B is implicated in myofibrillar protein loss in catabolic C2C12 myotubes.

Authors:  Cécile Polge; Roza Leulmi; Marianne Jarzaguet; Agnes Claustre; Lydie Combaret; Daniel Béchet; Anne-Elisabeth Heng; Didier Attaix; Daniel Taillandier
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-11-19       Impact factor: 12.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.